DK1467998T3 - Tetracykliske hetaroforbindelser som östrogenreceptormodulatorer - Google Patents
Tetracykliske hetaroforbindelser som östrogenreceptormodulatorerInfo
- Publication number
- DK1467998T3 DK1467998T3 DK02797167T DK02797167T DK1467998T3 DK 1467998 T3 DK1467998 T3 DK 1467998T3 DK 02797167 T DK02797167 T DK 02797167T DK 02797167 T DK02797167 T DK 02797167T DK 1467998 T3 DK1467998 T3 DK 1467998T3
- Authority
- DK
- Denmark
- Prior art keywords
- estrogen receptor
- receptor modulators
- hetero compounds
- tetracyclic
- tetracyclic hetero
- Prior art date
Links
- 239000002834 estrogen receptor modulator Substances 0.000 title 1
- 125000005842 heteroatom Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34195701P | 2001-12-19 | 2001-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1467998T3 true DK1467998T3 (da) | 2006-07-31 |
Family
ID=23339719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02797167T DK1467998T3 (da) | 2001-12-19 | 2002-12-02 | Tetracykliske hetaroforbindelser som östrogenreceptormodulatorer |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1467998B1 (da) |
| JP (1) | JP2005513133A (da) |
| CN (1) | CN1620457A (da) |
| AR (1) | AR038661A1 (da) |
| AT (1) | ATE321764T1 (da) |
| AU (1) | AU2002362041A1 (da) |
| BR (1) | BR0215152A (da) |
| CA (1) | CA2471107A1 (da) |
| CY (1) | CY1105361T1 (da) |
| DE (1) | DE60210333T2 (da) |
| DK (1) | DK1467998T3 (da) |
| ES (1) | ES2264737T3 (da) |
| HU (1) | HUP0500103A3 (da) |
| IL (1) | IL162295A0 (da) |
| MX (1) | MXPA04006034A (da) |
| NZ (1) | NZ533281A (da) |
| PL (1) | PL371045A1 (da) |
| PT (1) | PT1467998E (da) |
| RU (1) | RU2305099C2 (da) |
| WO (1) | WO2003053977A1 (da) |
| ZA (1) | ZA200405653B (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7105679B2 (en) | 2001-12-19 | 2006-09-12 | Kanojia Ramesh M | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| US7329654B2 (en) * | 2001-12-19 | 2008-02-12 | Janssen Pharmaceutica N.V. | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| EP1713820A1 (en) * | 2004-01-22 | 2006-10-25 | Eli Lilly And Company | Selective estrogen receptor modulators |
| CA2581223A1 (en) | 2004-09-20 | 2006-05-04 | Janssen Pharmaceutica N.V. | Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| BRPI0611670A2 (pt) | 2005-06-15 | 2016-11-16 | Fibrogen Inc | método para o tratamento ou prevenção de câncer em um indivíduo |
| DE102006024032A1 (de) * | 2006-05-23 | 2007-11-29 | Voith Patent Gmbh | Anordnung zur Bandregelung |
| RU2360670C1 (ru) * | 2007-10-03 | 2009-07-10 | Закрытое акционерное общество "Биологические исследования и системы" | Фармацевтическая композиция для местного и наружного применения при климактерических расстройствах на основе сигетина |
| DK2580210T5 (da) * | 2010-06-10 | 2017-06-19 | Seragon Pharmaceuticals Inc | Østrogenreceptormodulatorer og anvendelser deraf |
| EP2791133B1 (en) * | 2011-12-14 | 2019-04-17 | Seragon Pharmaceuticals, Inc. | Fluorinated estrogen receptor modulators and uses thereof |
| CN113135884B (zh) * | 2020-01-20 | 2023-03-10 | 西华大学 | 一种异色烯类化合物及其制备方法和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL124481C (da) * | 1964-11-04 | |||
| SU1607348A1 (ru) * | 1989-03-02 | 1994-09-30 | Пятигорский фармацевтический институт | 7-(3-фенилпропеноилокси)- 4' -фторизофлавон, обладающий гипотензивным действием |
| CA2214196A1 (en) * | 1996-09-26 | 1998-03-26 | Eli Lilly And Company | Benzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods |
| JP3251946B2 (ja) * | 1996-12-13 | 2002-01-28 | 中外製薬株式会社 | 新規なベンゾピラン誘導体 |
| RU2138669C1 (ru) * | 1997-07-02 | 1999-09-27 | Гнедых Александр Михайлович | Воздушный ракетный двигатель |
-
2002
- 2002-12-02 CN CNA028281446A patent/CN1620457A/zh active Pending
- 2002-12-02 AU AU2002362041A patent/AU2002362041A1/en not_active Abandoned
- 2002-12-02 DE DE60210333T patent/DE60210333T2/de not_active Expired - Fee Related
- 2002-12-02 HU HU0500103A patent/HUP0500103A3/hu unknown
- 2002-12-02 WO PCT/US2002/038486 patent/WO2003053977A1/en not_active Ceased
- 2002-12-02 ES ES02797167T patent/ES2264737T3/es not_active Expired - Lifetime
- 2002-12-02 IL IL16229502A patent/IL162295A0/xx unknown
- 2002-12-02 AT AT02797167T patent/ATE321764T1/de not_active IP Right Cessation
- 2002-12-02 MX MXPA04006034A patent/MXPA04006034A/es active IP Right Grant
- 2002-12-02 EP EP02797167A patent/EP1467998B1/en not_active Expired - Lifetime
- 2002-12-02 PT PT02797167T patent/PT1467998E/pt unknown
- 2002-12-02 CA CA002471107A patent/CA2471107A1/en not_active Abandoned
- 2002-12-02 PL PL02371045A patent/PL371045A1/xx not_active Application Discontinuation
- 2002-12-02 NZ NZ533281A patent/NZ533281A/en unknown
- 2002-12-02 BR BR0215152-9A patent/BR0215152A/pt not_active IP Right Cessation
- 2002-12-02 JP JP2003554693A patent/JP2005513133A/ja not_active Withdrawn
- 2002-12-02 DK DK02797167T patent/DK1467998T3/da active
- 2002-12-02 RU RU2004118606/04A patent/RU2305099C2/ru not_active IP Right Cessation
- 2002-12-18 AR ARP020104957A patent/AR038661A1/es unknown
-
2004
- 2004-07-15 ZA ZA200405653A patent/ZA200405653B/xx unknown
-
2006
- 2006-06-08 CY CY20061100768T patent/CY1105361T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003053977A1 (en) | 2003-07-03 |
| AR038661A1 (es) | 2005-01-26 |
| AU2002362041A1 (en) | 2003-07-09 |
| IL162295A0 (en) | 2005-11-20 |
| DE60210333D1 (de) | 2006-05-18 |
| CN1620457A (zh) | 2005-05-25 |
| CA2471107A1 (en) | 2003-07-03 |
| ZA200405653B (en) | 2006-06-28 |
| PL371045A1 (en) | 2005-06-13 |
| PT1467998E (pt) | 2006-08-31 |
| HUP0500103A2 (hu) | 2005-05-30 |
| RU2004118606A (ru) | 2006-01-10 |
| EP1467998A1 (en) | 2004-10-20 |
| NZ533281A (en) | 2007-05-31 |
| ES2264737T3 (es) | 2007-01-16 |
| CY1105361T1 (el) | 2010-03-03 |
| DE60210333T2 (de) | 2006-11-30 |
| RU2305099C2 (ru) | 2007-08-27 |
| MXPA04006034A (es) | 2005-03-31 |
| EP1467998B1 (en) | 2006-03-29 |
| BR0215152A (pt) | 2004-10-19 |
| JP2005513133A (ja) | 2005-05-12 |
| ATE321764T1 (de) | 2006-04-15 |
| HUP0500103A3 (en) | 2009-01-28 |
| HK1068875A1 (en) | 2005-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1173440T3 (da) | Tetracycliske azepinoindolforbindelser som 5-HT receptorligander | |
| DE60327767D1 (de) | Tricyclische steroidhormonkernrezeptor-modulatoren | |
| PT1444215E (pt) | Derivados de 1,2,4-triadiazolio como moduladores do receptor de melanocortina | |
| NO20042955L (no) | Substituerte fenylaftalener som estrogene midler | |
| IS6267A (is) | Ný spíróefnasambönd | |
| MA28391B1 (fr) | Dérivés de 3-cycloalkylaminopyrrolidine utiles comme modulateurs de récepteurs de chimiokines | |
| DK1668014T3 (da) | Kondenserede heterocykliske forbindelser som serotoninreceptormodulatorer | |
| EE200100567A (et) | Glükokortikoidretseptori modulaatorid | |
| DK1756096T3 (da) | Indolylderivater som lever-X-receptormodulatorer | |
| PL374215A1 (en) | Selective estrogen receptor modulators | |
| NO20051042L (no) | Pyrimidylsulfonamidderivater som kemokinreseptormodulatorer | |
| AU2002236114A1 (en) | Tricyclic androgen receptor modulator compounds | |
| PL376803A1 (pl) | Nowe pochodne tetracykliczne zawierające heteroatomy, jako selektywne modulatory receptora estrogenowego | |
| DK1467998T3 (da) | Tetracykliske hetaroforbindelser som östrogenreceptormodulatorer | |
| IL172759A0 (en) | Pyrrole-2,5-dithione derivatives as liver x receptor modulators | |
| EP1656142A4 (en) | 6-CYCLOAMINO-2-QUINOLINONE DERIVATIVES AS MODULATORS ANDROGEN RECEPTOR COMPOUNDS | |
| IL172760A0 (en) | Pyrrole-2,5-dithione derivatives as liver x receptor modulators | |
| AU2002335075A1 (en) | Estrogen receptor modulators | |
| DK1347974T3 (da) | Aminotriazolopyridinderivater som adenosinreceptorligander | |
| AU2003231523A1 (en) | Estrogen receptor modulators | |
| AU2001270822A1 (en) | Imidazolophthalazine derivatives as ligands for gabaa receptors | |
| DK1495030T3 (da) | Ikke-steroidale progesteronreceptormodulatorer | |
| NO20032415D0 (no) | Forbindelser som er aktive på glukokortikoidreseptor II | |
| AU2002235543A1 (en) | Imidazolophthalazine derivatives as ligands for gabaa receptors | |
| NO20015378D0 (no) | Cyclocarbamatderivater som progesteron reseptor modulatorer |